Literature DB >> 89602

Antiviral compound effective against experimental scrapie.

R H Kimberlin, C A Walker.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 89602     DOI： 10.1016/s0140-6736(79)91654-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Intraperitoneal infection with scrapie is established within minutes of injection and is non-specifically enhanced by a variety of different drugs.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 3.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

4.  Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome?

Authors:  H F Baker; R M Ridley; T J Crow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

5.  Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions.

Authors:  R H Kimberlin; C A Walker
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

6.  Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment.

Authors:  Isabel M Guijarro; Moisés Garcés; Pol Andrés-Benito; Belén Marín; Alicia Otero; Tomás Barrio; Margarita Carmona; Isidro Ferrer; Juan J Badiola; Marta Monzón
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

Review 7.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.